Breast Cancer Research and Treatment, Vol. 156, Issue 2 - New Issue Alert

If this email is not displayed correctly, please click here to read this table of contents online.

New Issue Alert 04/02/2016 Dear Alexandros Sfakianakis, We are pleased to deliver your requested table of contents alert for Breast Cancer Research and Treatment. Volume 156 Number 2 is now available online. Important news Change the World: Read 100+ Articles nominated by our Editors-in-Chief We asked our Editors-in-Chief to nominate just one journal article published in 2015 that could help humanity and protect and preserve our planet. Read all 100+ ground-breaking articles that have the potential to change the world, spanning all areas of science from astronomy to zoology. Free access expires July 15, 2016. » Learn more In this issue Review Developmental signaling pathways regulating mammary stem cells and contributing to the etiology of triple-negative breast cancer Maria Cristina Rangel, Daniel Bertolette, Nadia P. Castro, Malgorzata Klauzinska, Frank Cuttitta & David S. Salomon » Abstract   » Full text HTML   » Full text PDF Review A comparison of toxicity profiles between the lower and standard dose capecitabine in breast cancer: a systematic review and meta-analysis Tomohiro F. Nishijima, Maya Suzuki & Hyman B. Muss » Abstract   » Full text HTML   » Full text PDF Preclinical study Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer Hirofumi Matsumoto, Aye Aye Thike, Huihua Li, Joe Yeong, Si-lin Koo, Rebecca Alexandra Dent, Puay Hoon Tan & Jabed Iqbal » Abstract   » Full text HTML   » Full text PDF Preclinical study A novel gene expression signature for bone metastasis in breast carcinomas C. Dilara Savci-Heijink, Hans Halfwerk, Jan Koster & Marc J. van de Vijver » Abstract   » Full text HTML   » Full text PDF Preclinical study Effect of ALDH1 on prognosis and chemoresistance by breast cancer subtype Kumiko Kida, Takashi Ishikawa, Akimitsu Yamada, Kazuhiro Shimada, Kazutaka Narui, Sadatoshi Sugae, Daisuke Shimizu, Mikiko Tanabe, Takeshi Sasaki, Yasushi Ichikawa & Itaru Endo » Abstract   » Full text HTML   » Full text PDF Preclinical study Is ultrasound-guided fine-needle aspiration cytology of adequate value in detecting breast cancer patients with three or more positive axillary lymph nodes? G. M. Kramer, M. W. H. Leenders, L. J. Schijf, H. L. S. Go, T. van der Ploeg, M. P. van den Tol & W. H. Schreurs » Abstract   » Full text HTML   » Full text PDF Preclinical study Equivalence of MammaPrint array types in clinical trials and diagnostics Inès Beumer, Anke Witteveen, Leonie Delahaye, Diederik Wehkamp, Mireille Snel, Christa Dreezen, John Zheng, Arno Floore, Guido Brink, Bob Chan, Sabine Linn, Rene Bernards, Laura van 't Veer & Annuska Glas » Abstract   » Full text HTML   » Full text PDF Clinical Trial Adherence to the breast cancer surveillance program for women at risk for familial breast and ovarian cancer versus overscreening: a monocenter study in Germany Lisa Vetter, Monika Keller, Thomas Bruckner, Michael Golatta, Sabine Eismann, Christina Evers, Nicola Dikow, Christof Sohn, Jörg Heil & Sarah Schott » Abstract   » Full text HTML   » Full text PDF Clinical trial A phase I/II trial of the safety and clinical activity of a HER2-protein based immunotherapeutic for treating women with HER2-positive metastatic breast cancer Giuseppe Curigliano, Gilles Romieu, Mario Campone, Thierry Dorval, Lionel Duck, Jean-Luc Canon, Celia Roemer-Becuwe, Mario Roselli, Silvia Neciosup, Wivine Burny, Andrea Callegaro, Pedro Miguel de Sousa Alves, Jamila Louahed, Vincent Brichard & Frédéric F. Lehmann » Abstract   » Full text HTML   » Full text PDF Clinical trial Should the hyperechogenic halo around malignant breast lesions be included in the measurement of tumor size? Judith Joekel, Holm Eggemann, Serban Dan Costa & Atanas Ignatov » Abstract   » Full text HTML   » Full text PDF Clinical trial A non-randomized dose-escalation Phase I trial of a protein-based immunotherapeutic for the treatment of breast cancer patients with HER2-overexpressing tumors Steven A. Limentani, Mario Campone, Thierry Dorval, Giuseppe Curigliano, Richard de Boer, Charles Vogel, Shane White, Thomas Bachelot, Jean-Luc Canon, Mary Disis, Ahmad Awada, Martine Berlière, Frédéric Amant, Ellis Levine, Wivine Burny, Andrea Callegaro, Pedro Miguel de Sousa Alves, Jamila Louahed, Vincent Brichard & Frédéric F. Lehmann » Abstract   » Full text HTML   » Full text PDF Clinical trial Revisiting dosing regimen using PK/PD modeling: the MODEL1 phase I/II trial of docetaxel plus epirubicin in metastatic breast cancer patients Emilie Hénin, Christophe Meille, Dominique Barbolosi, Benoit You, Jérôme Guitton, Athanassios Iliadis & Gilles Freyer » Abstract   » Full text HTML   » Full text PDF Clinical trial Competing risks of death in women treated with adjuvant aromatase inhibitors for early breast cancer on NCIC CTG MA.27 Judith-Anne W. Chapman, Lois E. Shepherd, James N. Ingle, Hyman B. Muss, Kathleen I. Pritchard, Karen A. Gelmon, Timothy J. Whelan, Catherine Elliott & Paul E. Goss » Abstract   » Full text HTML   » Full text PDF Epidemiology Investigating racial disparities in use of NK1 receptor antagonists to prevent chemotherapy-induced nausea and vomiting among women with breast cancer Devon K. Check, Katherine E. Reeder-Hayes, Ethan M. Basch, Leah L. Zullig, Morris Weinberger & Stacie B. Dusetzina » Abstract   » Full text HTML   » Full text PDF Epidemiology The clinical value of HER-2 overexpression and PIK3CA mutations in the older breast cancer population: a FOCUS study analysis Charla C. Engels, Mandy Kiderlen, Esther Bastiaannet, Ronald van Eijk, Antien Mooyaart, Vincent T. H. B. M. Smit, Anton J. M. de Craen, Peter J. K. Kuppen, Judith R. Kroep, Cornelis J. H. van de Velde & Gerrit Jan Liefers » Abstract   » Full text HTML   » Full text PDF Epidemiology The impact of oophorectomy on survival after breast cancer in BRCA1-positive breast cancer patients T. Huzarski, T. Byrski, J. Gronwald, C. Cybulski, O. Oszurek, M. Szwiec, K. Gugała, M. Stawicka, Z. Morawiec, T. Mierzwa, M. Falco, H. Janiszewska, E. Kilar, E. Marczyk, B. Kozak-Klonowska, M. Siołek, D. Surdyka, R. Wiśniowski, M. Posmyk, P. Domagała, P. Sun, J. Lubiński & S. A. Narod » Abstract   » Full text HTML   » Full text PDF Epidemiology Effectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifen Marilyn L. Kwan, Jiaxiao M. Shi, Laurel A. Habel, Jun Song, Joanie W-L Chung, Chantal C. Avila, Joanne E. Schottinger, T. Craig Cheetham, Suzanne W. Fletcher & Reina Haque » Abstract   » Full text HTML   » Full text PDF Epidemiology Very low local recurrence rates after breast-conserving therapy: analysis of 8485 patients treated over a 28-year period S. C. J. Bosma, F. van der Leij, E. van Werkhoven, H. Bartelink, J. Wesseling, S. Linn, E. J. Rutgers, M. J. van de Vijver & P. H. M. Elkhuizen » Abstract   » Full text HTML   » Full text PDF Erratum Erratum to: Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue Myriam Vilasco, Laudine Communal, Justine Hugon-Rodin, Frédérique Penault-Llorca, Najat Mourra, Zherui Wu, Patricia Forgez & Anne Gompel » Abstract   » Full text HTML   » Full text PDF Erratum Erratum to: Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients Jun Tang, Rong Deng, Rong-Zhen Luo, Guo-Ping Shen, Mu-Yan Cai, Zi-Ming Du, Shan Jiang, Ming-Tian Yang, Jian-Hua Fu & Xiao-Feng Zhu » Abstract   » Full text HTML   » Full text PDF Erratum Erratum to: PI3K/mTOR inhibition can impair tumor invasion and metastasis in vivo despite a lack of antiproliferative action in vitro: implications for targeted therapy Seth A. Wander, Dekuang Zhao, Alexandra H. Besser, Feng Hong, Jianqin Wei, Tan A. Ince, Clara Milikowski, Nanette H. Bishopric, Andy J. Minn, Chad J. Creighton & Joyce M. Slingerland » Abstract   » Full text HTML   » Full text PDF Erratum Erratum to: RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial–mesenchymal transition Chonggao Yin, Hongli Li, Baogang Zhang, Yuqing Liu, Guohua Lu, Shijun Lu, Lei Sun, Yueliang Qi, Xiaolong Li & Weiyi Chen » Abstract   » Full text HTML   » Full text PDF Erratum Erratum to: Estrogen receptor beta binds Sp1 and recruits a corepressor complex to the estrogen receptor alpha gene promoter V. Bartella, P. Rizza, I. Barone, D. Zito, F. Giordano, C. Giordano, S. Catalano, L. Mauro, D. Sisci, M. L. Panno, S. A. W. Fuqua & S. Andò » Abstract   » Full text HTML   » Full text PDF Do you want to publish your article in this journal? Please visit the homepage of Breast Cancer Research and Treatment for full details on: aims and scope editorial policy article submission Impact Factor: 3.940 (2014) Journal Citation Reports®, Thomson Reuters Read open access articles Click here to view all open access articles published in this journal. Interested in publishing your article open access? When you opt for Open Choice, you retain full copyright and your article is permanently freely available. Sign up for SpringerAlerts! Register for Springer's email services providing you with info on the latest books in your field. » Click here Important news Change the World: Read 100+ Articles nominated by our Editors-in-Chief We asked our Editors-in-Chief to nominate just one journal article published in 2015 that could help humanity and protect and preserve our planet. Read all 100+ ground-breaking articles that have the potential to change the world, spanning all areas of science from astronomy to zoology. Free access expires July 15, 2016. » Learn more This email has been sent to alsfakia.journals2@blogger.com You are receiving this email because you have opted to receive information from SpringerAlerts as a registered user of our Table of Content Alert for journals. To ensure the delivery to your inbox, please add the sender address springer@alerts.springer.com to your allow list. To modify your subscription (including change of email address etc.), please go to http://ift.tt/Lqiruf and log in with your email address and password. To unsubscribe from this specific table of contents alert, please click here. To unsubscribe from ALL table of contents alerts, please click here. For all enquiries, problems or suggestions regarding this service, please contact onlineservice@springer.com. Springer respects your privacy and does not disclose, sell or rent your personal information to any nonaffiliated third parties without your consent. Please visit the Springer Privacy Statement. Springer-Verlag GmbH Heidelberg, Tiergartenstrasse 17, 69121 Heidelberg, Germany, phone: +49 6221 487 0, fax: +49 6221 487 8366 © Springer 2016, springer.com

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1qcwicU
via IFTTT